Guangzhou LBP Medicine Science & Technology Co Ltd. Stock Analysis 688393.SS

Guangzhou LBP Medicine Science & Technology Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and instruments. The company is headquartered in Guangzhou, Guangdong and currently employs 768 full-time employees. The company went IPO on 2020-08-20. The firm's main business focuses on tumor screening and precision diagnosis, and the application department is mainly pathology. The firm provides a series of tumor screening and diagnostic reagents, automated equipment and auxiliary diagnosis artificial intelligence software. The firm also provides multiple operating models for the construction of specialized alliance pathology diagnosis centers, grassroots pathology departments, and cervical cancer intelligent screening centers, and is equipped with pathology equipment, reagents and consumables, digital and artificial intelligence products, diagnostic services, and technical support. The firm mainly operates its businesses in the domestic and overseas markets.